Skip to content
Riskpilot
← Back to search
Sign in
Get full access
byLink ApS
APS
Active
Advertising protection
CVR 40568158
Østre Alle 6, 9530
Støvring
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2019 · 7 years old
6 employees
www.bylink.dk
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
byLink ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
1M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
551
999
956
910
989
Staff expenses
-548
-774
-898
-875
-908
EBITDA
4
225
58
35
81
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
4
225
58
35
81
Net financials
-1
0
-0
-1
-0
Profit before tax
3
225
58
34
80
Tax
2
50
15
9
19
Net profit
1
175
42
25
61
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
197
456
439
509
859
Equity
108
283
325
351
412
Long-term debt
0
0
0
0
0
Short-term debt
89
173
114
158
447
Total debt
89
173
114
158
447
Financial ratios
5-year trend
EBITDA margin (of gross profit)
8.2%
This company
2021
2025
Equity ratio
47.9%
This company
38.2%
Market median
+25% vs market
2021
2025
Return on equity
14.9%
This company
18.4%
Market median
+19% vs market
2021
2025
Net profit margin (of gross profit)
6.2%
This company
2021
2025
Asset turnover (of gross profit)
1.15×
This company
2021
2025
Debt / equity
1.09×
This company
0.62×
Market median
-76% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
View
PDF
More on byLink ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network